Books / Special Reports:

• Royalty Rates for Pharmaceuticals & Biotechnology, 8th Edition This report contains hundreds of royalty rates and financial compensation benchmarks to optimize the pricing of biotechnology and pharmaceutical innovations ... more »

• Royalty Rates in Biotech: BVR’s Guide to Full-Text Licensing Agreements With this report we've gathered over 500 pages of hard-to-find full-text copies of actual licensing agreements in the biotech industry ... more »

• The Medical Innovation Playbook The Medical Innovation Playbook is the first-ever resource documenting commercialization activity and results at the country’s top academic medical centers ... more »

Distance Learning:

• Accelerating Biomedical Innovation and Commercialization in the University Setting: The University of Michigan Fast-Forward Medical Innovation Program The leadership of University of Michigan’s Fast Forward Medical Innovation program will detail their best practices and strategies ... more »

• All Access Pass This program gives you and your staff a complete arsenal of tech transfer benchmarks, best practices, and success strategies – at your fingertips 24/7 ... more »

• Analyzing and Adapting to the Supreme Court’s Myriad Ruling One of the world’s top life sciences patent attorneys will help clarify and assess Myriad’s effects for IP and research commercialization professionals ... more »

• Antibody Patenting and Licensing Challenges in Light of Amgen v. Sanofi Explore the current state of the law regarding written description and claim scope and the effects of these changes ... more »

• Cannabis Research and Commercialization: Best Practices for University IP Protection This program will explore the unique challenges in protecting IP surrounding Cannabis created by its conflicting legal status between state and federal law ... more »

• CRISPR Confusion: A Legal and Practical Analysis for IP Professionals Analysis and impact of how legal disputes over patent rights have clouded the prospects for broad dissemination of CRISPR technology ... more »

• Getting to a License: Valuation and Strategic Marketing of Biotech, Therapeutics and other Life Science IP Assets Get a detailed blueprint for valuing life sciences assets that takes into account the needs and requirements of both industry partners and the university ... more »

• Home Run Strategies: Finding, Nurturing, and Securing Maximum Revenues from Disruptive University Technologies Just a few technologies out of the thousands patented and licensed each year account for 95% of revenues generated by research commercialization activities. ... more »

• How Your University’s Innovations Can Become a Fixture in Big Pharma's Pipeline Pharma companies are struggling not only with poor pipeline performance, but also increasing reimbursement, regulatory and economic pressures. ... more »

• In-Depth Analysis of Mayo v. Prometheus: What it Means for the Future of Medical Diagnostic Patents This program will help you make sense of the complex issues raised by the decision and to understand how to adjust your patent strategy accordingly. ... more »

• Myriad: The Gene Patent Fight Continues... Find out what the Myriad decision means for TTOs and university researchers with gene-based innovations, in terms of both patenting and licensing ... more »

• The Future of Patenting in Biomedicine This program goes beyond legal theory to address strategies that universities and innovators can use to ensure patent protection and maximize investment. ... more »

Software / Tools:

• Easy eNPV™ This software tool provides its users with the ability to accurately forecast the financial performance of new drug candidates and produce valuations ... more »

• The Life Science Venture Capital Directory The Life Science Venture Capital Director is an easy, low-cost, time-saving source of contact information for VC firms available for immediate download ... more »